Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1118307411 | 11183074 | 11 | F | 20150219 | 20160918 | 20150611 | 20160926 | EXP | PHHY2015IL022120 | NOVARTIS | 61.01 | YR | M | Y | 89.00000 | KG | 20160926 | CN | COUNTRY NOT SPECIFIED | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1118307411 | 11183074 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | U | S0071, S0074, S0076 | 22068 | 300 | MG | CAPSULE | BID | ||||
| 1118307411 | 11183074 | 2 | C | ENALADEX | ENALAPRIL MALEATE | 1 | Unknown | U | 0 | ||||||||||
| 1118307411 | 11183074 | 3 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | ||||||||||
| 1118307411 | 11183074 | 4 | C | CARDILOC | BISOPROLOL FUMARATE | 1 | Unknown | U | 0 | ||||||||||
| 1118307411 | 11183074 | 5 | C | MICROPIRIN | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 1118307411 | 11183074 | 6 | C | AMARYL | GLIMEPIRIDE | 1 | Unknown | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 1118307411 | 11183074 | 7 | C | AMARYL | GLIMEPIRIDE | 1 | Unknown | 1 MG, BID | 0 | 1 | MG | BID | |||||||
| 1118307411 | 11183074 | 8 | C | SIMVACOR | SIMVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 1118307411 | 11183074 | 9 | C | BEZAFIBRATE | BEZAFIBRATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1118307411 | 11183074 | 1 | Chronic myeloid leukaemia |
| 1118307411 | 11183074 | 2 | Hypertension |
| 1118307411 | 11183074 | 3 | Product used for unknown indication |
| 1118307411 | 11183074 | 4 | Cardiac disorder |
| 1118307411 | 11183074 | 5 | Product used for unknown indication |
| 1118307411 | 11183074 | 6 | Type 2 diabetes mellitus |
| 1118307411 | 11183074 | 8 | Blood cholesterol increased |
| 1118307411 | 11183074 | 9 | Blood triglycerides abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1118307411 | 11183074 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1118307411 | 11183074 | Asthenia | |
| 1118307411 | 11183074 | Blood creatinine increased | |
| 1118307411 | 11183074 | Blood glucose increased | |
| 1118307411 | 11183074 | Blood triglycerides increased | |
| 1118307411 | 11183074 | Diabetes mellitus inadequate control | |
| 1118307411 | 11183074 | Eye haemorrhage | |
| 1118307411 | 11183074 | Glycosylated haemoglobin increased | |
| 1118307411 | 11183074 | Hyperhidrosis | |
| 1118307411 | 11183074 | Proteinuria | |
| 1118307411 | 11183074 | Vision blurred | |
| 1118307411 | 11183074 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1118307411 | 11183074 | 1 | 20150201 | 0 | ||
| 1118307411 | 11183074 | 7 | 20160108 | 0 |